Comparative evaluation of orally active antibiotics against community-acquired pathogens: Results of eight european countries

Chemotherapy

Volumn 42, Issue 1, 1996, Pages 11-20

  Cullmann, W ^a  

^a Bürgerhospital Stuttgart ^*  (Germany)

Author keywords

Cephalosporins, oral; Doxycycline; Epidemiological situation, Europe; Erythromycin; Penicillin compounds, oral; Penicillin resistant Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFACLOR; CEFETAMET; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ARTICLE; CITROBACTER FREUNDII; COMMUNICABLE DISEASE; CONTROLLED STUDY; CROSS RESISTANCE; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FINLAND; GERMANY; GREECE; HAEMOPHILUS INFLUENZAE; HUNGARY; ITALY; KLEBSIELLA PNEUMONIAE; MORAXELLA CATARRHALIS; NETHERLANDS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROTEUS VULGARIS; SALMONELLA; SHIGELLA; SPAIN; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; SWITZERLAND;

ADMINISTRATION, ORAL; ANTIBIOTICS; BACTERIAL INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; COMPARATIVE STUDY; DRUG RESISTANCE, MICROBIAL; EUROPE; HUMAN; MICROBIAL SENSITIVITY TESTS;

EID: 0029655394     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239418     Document Type: Article

References (15)

1. Bauernfeind A, Jungwirth R: Antibacterial activity of Cefpodoxime in comparison with ccfixime, cefdinir. cefetamct, ceftibuten, loracarbef. cefprozil, BAY 3522, cefuroxime, cefaclor and ccfadroxil. Infection 1991;19:353-362.
2. Holt HA, Bywartcr MJ, Reeves DS: In vitro activity of ccfpodoxime against 1834 isolates from domiciliary infections at 20 UK centres. J Antimicrob Chemothcr 1990;26 (suppl E):7-12.
3. Sheppard M, King A, Phillips I; In vitro activity of cefpodoximc. a new oral cephalosporin, compared with that of nine other antimicrobial agents. Eur J Clin Microbiol Infect Dis 1991;10:573-581.
4. Soussy CI, Kitzis MD, Thabaut A, Chanal M, Bure A, Vergnaud M, Reynaud AE. Coulet M, Dabemat H, Muller-Scrieys C, et al: Activité antibacterienne in vitro d'une nouvelle Cephalosporine orale, le cefi xime. Résultats d'une étude multri-centrique. Pathol Biol 1989,37:528-533.
5. Wiedemann B, Luhmer E, Zuhldorf MT: In vitro activity of Cefpodoxime and ten other cephalosporins against Gram-positive cocci, Ente-robacteriaceae and Pseudomonas aeruginosa, including beta-lacta-mase producers. Infection 1991:19: 363-369.
6. Balows A, Hausler WJ, Herrmann KL, Isenberg HD. Shadomy HJ: Manual of Clinical Microbiology. Washington, American Society for Microbiology, 1991.
7. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Susceptibility Testing. NCCLS Document M100-S5 Villanova, National Committee for Clinical Laboratory Standards, 1994, vol 14, N 16.
8. Fenoll A, Martin BourgonC, Munoz R, Vicioso D, Casai J: Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis 1991;13:56-60.
9. Marton A, Gulyas M, Munoz R, To-masz A: Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J Infect Dis 1991.163: 542-548.
10. Cullmann W: Lcs beta lactamases de Moraxella catarrkalis.Med Mai Infect 1992;22:529-534.
11. Yokota E, Fujii T, Sato K, Inoue M, Mitsuhashi S: Purification and properties of a p-lactamase produced by Branhamella catarrha-lis.Antimicrob Agents Chcmother 1986;29:696-698.
12. Medeiros AA, O'Brien TF: Ampicil-lin-resistant Haemophilus influenzae type B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin. Lancet 1975:i:716.
13. Cullmann W: Beta-lactamascs in the Gram-ncgatives: Different types and their contribution to phenotypic resistance. Antiinfect Drugs Che-mother (Munich) 1994;12:36-43.
14. Mancini R, Massida O, Satta G: Rate of penetration of cefetamet. ce-fixime, cefuroxime, and cefaclor in different strains of Entcrobacteria-ceae. Mid Mai Infect 1992;22:544-547.
15. Cullmann W: Microbiology of oral cephalosporins; in Schonfeld H (cd): Antibiotics and Chemotherapy. Basel, Karger, 1995, in press.